Helicobacter pylori infection increases the risk of colorectal adenoma and adenocarcinoma, especially in women

被引:62
作者
Fujimori, S
Kishida, T
Kobayashi, T
Sekita, Y
Seo, T
Nagata, K
Tatsuguchi, A
Gudis, K
Yokoi, K
Tanaka, N
Yamashita, K
Tajiri, T
Ohaki, Y
Sakamoto, C
机构
[1] Nippon Med Coll, Dept Internal Med 3, Bunkyo Ku, Tokyo 1138603, Japan
[2] Nippon Med Coll, Dept Surg 1, Tokyo, Japan
[3] Nippon Med Coll, Dept Pathol, Tokyo, Japan
关键词
colorectal adenoma; colorectal adenocarcinoma; Helicobacter pylori; colon cancer;
D O I
10.1007/s00535-005-1649-1
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background. Recent reports suggest that Helicobacter pylori infection can potentially increase the risk of colorectal cancer. The purpose of this study was to assess the association between H. pylori infection and the risk of colorectal adenoma and adenocarcinoma, and to evaluate any differences on the basis of sex. Methods. The subjects were 669 (40- to 80-year-old) patients who underwent both barium enema examination and total colonoscopy, and who were evaluated for H. pylori infection by C-13-urea breath test, urease test, or histological diagnosis of biopsied gastric specimens. There were 142 H. pylori-negative and 527-positive patients. The odds ratios (ORs) for H. pylori-positive patients with colorectal adenoma and adenocarcinoma, and for tumor patients with either adenoma or adenocarcinoma were calculated. Results. Among the H. pylori-negative patients, there were 52 patients without tumor, 63 with adenoma, 27 with adenocarcinoma, and 90 with tumor. Among the H. pylori-positive patients, there were 136, 264, 127, and 391 patients respectively. Pooling all subjects, those infected with H. pylori had a significantly increased OR for adenoma, adenocarcinoma, or tumor, compared to H. pylori-free patients (OR, 1.60, 1.80, and 1.66, respectively). For female H. pylori-positive subjects, the risk of having adenocarcinoma or tumor was significantly higher than that for their H. pylori-free counterparts, while for male H. pylori-positive and -negative subjects, there was no such significant difference. Conclusions. The results therefore suggest that, in patients aged 40-80 years, H. pylori infection increased the risk of colorectal adenoma and adenocarcinoma, with significantly higher risks for female patients.
引用
收藏
页码:887 / 893
页数:7
相关论文
共 40 条
[1]   Recombination and clonal groupings within Helicobacter pylori from different geographical regions [J].
Achtman, M ;
Azuma, T ;
Berg, DE ;
Ito, Y ;
Morelli, G ;
Pan, ZJ ;
Suerbaum, S ;
Thompson, SA ;
van der Ende, A ;
van Doorn, LJ .
MOLECULAR MICROBIOLOGY, 1999, 32 (03) :459-470
[2]  
ASAKA M, 1994, CANCER, V73, P2691, DOI 10.1002/1097-0142(19940601)73:11<2691::AID-CNCR2820731107>3.0.CO
[3]  
2-2
[4]   Colorectal adenomateous polyps and Helicobacter pylori infection [J].
Aydin, A ;
Karasu, Z ;
Zeytinoglu, A ;
Kumanlioglu, K ;
Özacar, T .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 1999, 94 (04) :1121-1122
[5]   Distinct diversity of the cag pathogenicity island among Helicobacter pylori strains in Japan [J].
Azuma, T ;
Yamakawa, A ;
Yamazaki, S ;
Ohtani, M ;
Ito, Y ;
Muramatsu, A ;
Suto, H ;
Yamazaki, Y ;
Keida, Y ;
Higashi, H ;
Hatakeyama, M .
JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (06) :2508-2517
[6]   Helicobacter pylori and the risk of colonic adenomas [J].
Breuer-Katschinski, B ;
Nemes, K ;
Marr, A ;
Rump, B ;
Leiendecker, B ;
Breuer, N ;
Goebell, H .
DIGESTION, 1999, 60 (03) :210-215
[7]   DIFFERENTIAL-EFFECTS OF ORAL CONJUGATED ESTROGENS AND TRANSDERMAL ESTRADIOL ON INSULIN-LIKE GROWTH-FACTOR-1, GROWTH-HORMONE AND SEX-HORMONE BINDING GLOBULIN SERUM LEVELS [J].
CAMPAGNOLI, C ;
BIGLIA, N ;
ALTARE, F ;
LANZA, MG ;
LESCA, L ;
CANTAMESSA, C ;
PERIS, C ;
FIORUCCI, GC ;
SISMONDI, P .
GYNECOLOGICAL ENDOCRINOLOGY, 1993, 7 (04) :251-258
[8]   Estrogen plus progestin and colorectal cancer in postmenopausal women [J].
Chlebowski, RT ;
Wactawski-Wende, J ;
Ritenbaugh, C ;
Hubbell, FA ;
Ascensao, J ;
Rodabough, RJ ;
Rosenberg, CA ;
Taylor, VM ;
Harris, R ;
Chen, C ;
Adams-Campbell, LL ;
White, E ;
Alving, B ;
Rossouw, J ;
Pottern, L ;
Ludlam, S ;
McGowan, J ;
Prentice, R ;
Anderson, G ;
LaCroix, A ;
Patterson, R ;
McTiernan, A ;
Cochrane, B ;
Hunt, J ;
Tinker, L ;
Kooperberg, C ;
McIntosh, M ;
Wang, CY ;
Chen, C ;
Bowen, D ;
Kristal, A ;
Stanford, J ;
Urban, N ;
Weiss, N ;
White, E ;
Shumaker, S ;
Rautaharju, P ;
Prineas, R ;
Naughton, M ;
Stein, E ;
Laskarzewski, P ;
Cummings, S ;
Nevitt, M ;
Dockrell, M ;
Harnack, L ;
Cammarata, F ;
Lindenfelser, S ;
Psaty, B ;
Heckbert, S ;
Wassertheil-Smoller, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (10) :991-1004
[9]  
CHRISTINE JK, 1986, AM J PHYSIOL, V251, pG597
[10]  
CLINTON SK, 1988, CANCER RES, V48, P3035